Peritoneal Carcinomatosis From Ovarian Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Peritoneal Carcinomatosis From Ovarian Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT04847063

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per…

Background: Cytoreductive surgery (CRS) removes tumors in the abdomen. HIPEC is hyperthermic (heated) chemotherapy that washes the inside of the abdomen. CRS w…

United States60 participantsStarted 2021-10-19

Treatment: Sodium Thiosulfate, 5-Fluorouracil

All recent trials (10 shown)

Active — Not RecruitingPhase 2

NCT05185947

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Ap…

Background: Tumors that have spread to the lining of the abdomen from other cancers, such as cancer of the appendix, colon, or ovary, are called peritoneal car…

United States19 participantsStarted 2022-10-13

Treatment: Paclitaxel, Nilotinib

CompletedNot Applicable

NCT06789224

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxo…

The REMOVE study was an open-label, multicenter validation study on the removal of EpCAM-positive tumor cells from blood collected during tumor surgery using th…

Germany136 participantsStarted 2022-02-15

Treatment: CATUVAB

Peritoneal Carcinomatosis From Ovarian Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per…

All recent trials (10 shown)

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Ap…

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxo…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per…

All recent trials (10 shown)

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Ap…

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxo…

Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal…

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) : Predictive Marker and Mechanism

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cy…

Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritone…

Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatos…

Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic Consequences

Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients